603 related articles for article (PubMed ID: 22168961)
21. Endurance shuttle walking test: responsiveness to salmeterol in COPD.
Brouillard C; Pepin V; Milot J; Lacasse Y; Maltais F
Eur Respir J; 2008 Mar; 31(3):579-84. PubMed ID: 18057052
[TBL] [Abstract][Full Text] [Related]
22. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.
Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR
Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646
[TBL] [Abstract][Full Text] [Related]
23. Helium-hyperoxia, exercise, and respiratory mechanics in chronic obstructive pulmonary disease.
Eves ND; Petersen SR; Haykowsky MJ; Wong EY; Jones RL
Am J Respir Crit Care Med; 2006 Oct; 174(7):763-71. PubMed ID: 16840742
[TBL] [Abstract][Full Text] [Related]
24. Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial.
Beeh KM; Singh D; Di Scala L; Drollmann A
Int J Chron Obstruct Pulmon Dis; 2012; 7():503-13. PubMed ID: 22973092
[TBL] [Abstract][Full Text] [Related]
25. Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance.
Ora J; Laveneziana P; Ofir D; Deesomchok A; Webb KA; O'Donnell DE
Am J Respir Crit Care Med; 2009 Nov; 180(10):964-71. PubMed ID: 19897773
[TBL] [Abstract][Full Text] [Related]
26. Physiologic effects of an ambulatory ventilation system in chronic obstructive pulmonary disease.
Porszasz J; Cao R; Morishige R; van Eykern LA; Stenzler A; Casaburi R
Am J Respir Crit Care Med; 2013 Aug; 188(3):334-42. PubMed ID: 23741986
[TBL] [Abstract][Full Text] [Related]
27. Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease.
Casaburi R; Maltais F; Porszasz J; Albers F; Deng Q; Iqbal A; Paden HA; O'Donnell DE;
Ann Am Thorac Soc; 2014 Nov; 11(9):1351-61. PubMed ID: 25289942
[TBL] [Abstract][Full Text] [Related]
28. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function.
Cooper CB
Am J Med; 2006 Oct; 119(10 Suppl 1):21-31. PubMed ID: 16996896
[TBL] [Abstract][Full Text] [Related]
29. Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD.
Corda L; Bertella E; La Piana GE; Boni E; Redolfi S; Tantucci C
Respiration; 2008; 76(1):61-8. PubMed ID: 18319586
[TBL] [Abstract][Full Text] [Related]
30. Effect of obesity on respiratory mechanics during rest and exercise in COPD.
Ora J; Laveneziana P; Wadell K; Preston M; Webb KA; O'Donnell DE
J Appl Physiol (1985); 2011 Jul; 111(1):10-9. PubMed ID: 21350021
[TBL] [Abstract][Full Text] [Related]
31. Effects of formoterol on exercise tolerance in severely disabled patients with COPD.
Neder JA; Fuld JP; Overend T; Thirlwell J; Carter R; Stevenson R; Ward SA
Respir Med; 2007 Oct; 101(10):2056-64. PubMed ID: 17658249
[TBL] [Abstract][Full Text] [Related]
32. Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease.
Ong KC; Kor AC; Chong WF; Earnest A; Wang YT
Am J Respir Crit Care Med; 2004 May; 169(9):1028-33. PubMed ID: 14977622
[TBL] [Abstract][Full Text] [Related]
33. Effect of biventricular pacing on ventilatory and perceptual responses to exercise in patients with stable chronic heart failure.
Laveneziana P; O'Donnell DE; Ofir D; Agostoni P; Padeletti L; Ricciardi G; Palange P; Duranti R; Scano G
J Appl Physiol (1985); 2009 May; 106(5):1574-83. PubMed ID: 19246658
[TBL] [Abstract][Full Text] [Related]
34. A randomized, placebo-controlled trial of acupuncture in patients with chronic obstructive pulmonary disease (COPD): the COPD-acupuncture trial (CAT).
Suzuki M; Muro S; Ando Y; Omori T; Shiota T; Endo K; Sato S; Aihara K; Matsumoto M; Suzuki S; Itotani R; Ishitoko M; Hara Y; Takemura M; Ueda T; Kagioka H; Hirabayashi M; Fukui M; Mishima M
Arch Intern Med; 2012 Jun; 172(11):878-86. PubMed ID: 22905352
[TBL] [Abstract][Full Text] [Related]
35. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease.
O'Donnell DE; Lam M; Webb KA
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1557-65. PubMed ID: 9817708
[TBL] [Abstract][Full Text] [Related]
36. Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD.
Berton DC; Reis M; Siqueira AC; Barroco AC; Takara LS; Bravo DM; Andreoni S; Neder JA
Respir Med; 2010 Sep; 104(9):1288-96. PubMed ID: 20580216
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of procaterol on exercise dynamic lung hyperinflation during the 6-min walk test in stable patients with chronic obstructive pulmonary disease.
Satake M; Takahashi H; Sugawara K; Kawagoshi A; Tamaki A; Homma M; Morita R; Sato K; Sano M; Shioya T
Arzneimittelforschung; 2011; 61(1):8-13. PubMed ID: 21355441
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the effects of olodaterol on exercise endurance in patients with chronic obstructive pulmonary disease: results from two 6-week crossover studies.
Maltais F; Kirsten AM; Hamilton A; De Sousa D; Voß F; Decramer M
Respir Res; 2016 Jul; 17(1):77. PubMed ID: 27383762
[TBL] [Abstract][Full Text] [Related]
39. Inspiratory neural drive and dyspnea in interstitial lung disease: Effect of inhaled fentanyl.
Milne KM; Ibrahim-Masthan M; Scheeren RE; James MD; Phillips DB; Moran-Mendoza O; Ja N; O'Donnell DE
Respir Physiol Neurobiol; 2020 Nov; 282():103511. PubMed ID: 32758677
[TBL] [Abstract][Full Text] [Related]
40. Effect of endurance training on expiratory flow limitation and dynamic hyperinflation in patients with stable chronic obstructive pulmonary disease.
Chen R; Chen R; Chen X; Chen L
Intern Med J; 2014 Aug; 44(8):791-800. PubMed ID: 24860934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
